Sheel Biotech Limited (NSE:SHEEL)
India flag India · Delayed Price · Currency is INR
58.30
-2.70 (-4.43%)
At close: Nov 17, 2026

Sheel Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,3891,1001,018922.82801.16707.36
Revenue Growth
26.25%8.13%10.26%15.19%13.26%12.23%
Gross Profit
459.31405.9360.37346.6259.73229.09
Operating Income
238.2198.14141.11135.4978.1755.3
Net Income
149.53117.56107.55104.7550.7748.57
Earnings Per Share
7.296.697.287.223.503.35
EPS Growth
8.93%-8.10%0.83%106.29%4.51%-65.58%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2.1191.7820.718.314.73.11
Total Debt
197.9389.79173.61235.4191.71235.83
Net Cash (Debt)
-195.821.99-152.91-217.1-177.01-232.72
Net Cash Growth
------
Net Cash Per Share
-9.540.11-10.35-14.97-12.20-16.05

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-150.59-175.6985.15-9.292.9221.91
Capital Expenditures
-136.77-66.6-12.38-2.94-11.55-12.09
Free Cash Flow
-287.35-242.2872.76-12.1481.389.81
Free Cash Flow Growth
----729.34%-

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
33.06%36.89%35.42%37.56%32.42%32.39%
Operating Margin
17.15%18.01%13.87%14.68%9.76%7.82%
Pretax Margin
12.88%12.74%12.60%13.28%7.95%6.86%
Profit Margin
10.76%10.69%10.57%11.35%6.34%6.87%
FCF Margin
-20.69%-22.02%7.15%-1.31%10.16%1.39%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
8.006.93----
PS Ratio
0.890.74----